Are hemorrhagic (containing blood) or proteinaceous (containing protein) renal cysts present?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hemorrhagic or proteinaceous renal cysts can be present and are characterized by homogeneous high T1 signal intensity lesions with smooth borders and a lesion to renal parenchyma signal intensity ratio of >1.6 on MRI.

Characteristics of Hemorrhagic or Proteinaceous Cysts

  • Homogeneous high T1 signal intensity lesions
  • Smooth borders
  • Lesion to renal parenchyma signal intensity ratio of >1.6 These characteristics can help differentiate them from renal cell carcinoma (RCC) 1.

Diagnostic Approaches

  • MRI without and with IV contrast is optimal for renal lesion characterization
  • MRI without IV contrast can also provide diagnostic information, such as characterizing simple cystic lesions or those with thin septations on noncontrast T2-weighted imaging
  • Diffusion-weighted imaging and specialized MRI sequences, like arterial spin labeling, may also be used to characterize renal lesions 1.

Classification and Management

  • The Bosniak classification system is used to distinguish five categories of renal cystic masses based on CT or MRI diagnostic criteria, predicting the risk of malignancy and guiding management 1.
  • Bosniak III cysts have a 10% risk of malignancy, and cautious surveillance is a reasonable alternative to primary surgery, as many of these lesions have low malignant potential 1.

From the Research

Presence of Hemorrhagic or Proteinaceous Renal Cysts

  • Hemorrhagic renal cysts are present, as evidenced by a case report of a 73-year-old male with a right renal cyst containing echogenic debris consistent with a hemorrhagic cyst 2.
  • Proteinaceous renal cysts are also present, with a study reporting that most hyperattenuating renal masses are benign hemorrhagic or proteinaceous cysts 3.
  • A case report of a 21-year-old patient with a spontaneous rupture of a simple renal cyst complicated by hemorrhagic shock also supports the presence of hemorrhagic renal cysts 4.
  • The high protein concentration in a renal cyst can cause high attenuation values on computed tomography, making it a cause of CT hyperdense benign renal cysts 5.
  • A retrospective analysis of 204 patients found that T1-weighted lesion-to-muscle signal-intensity ratio can be used to distinguish between hemorrhagic cysts and renal cell carcinomas, with a optimal cutoff value of 1.39 6.

Characteristics of Hemorrhagic and Proteinaceous Renal Cysts

  • Hemorrhagic renal cysts often have irregular borders and echogenic material within their walls and within the cyst 2.
  • Proteinaceous renal cysts can have high attenuation values on computed tomography due to the high protein concentration 5.
  • Hemorrhagic cysts can be distinguished from malignant tumors using computed tomography or magnetic resonance imaging 2, 6.
  • The presence of internal echoes, septations, or calcifications can indicate a complex renal cyst, which may be hemorrhagic or infected 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemorrhagic Renal Cyst, a Case Report.

Journal of education & teaching in emergency medicine, 2020

Research

Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2007

Research

High protein content: another cause of CT hyperdense benign renal cyst.

Journal of computer assisted tomography, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.